CRISPR/Cas9 Cellular Engineering for the Creation of Coagulation Factor-Based Resuscitation Fluid to Combat Hemorrhage and Coagulopathy

Project: Research project

Project Details

Description

CRISPR/Cas9 Cellular Engineering for the Creation of Coagulation Factor-Based Resuscitation Fluid to Combat Hemorrhage and Coagulopathy
StatusActive
Effective start/end date6/16/206/15/21

Funding

  • THE GENEVA FOUNDATION

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.